Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 720 | 2021 |
The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo H Akiba, K Takeda, Y Kojima, Y Usui, N Harada, T Yamazaki, J Ma, ... The Journal of Immunology 175 (4), 2340-2348, 2005 | 478 | 2005 |
Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells N Harada, M Nakayama, H Nakano, Y Fukuchi, H Yagita, K Okumura Biochemical and biophysical research communications 299 (3), 488-493, 2002 | 227 | 2002 |
Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death M Nakayama, K Ishidoh, Y Kojima, N Harada, E Kominami, K Okumura, ... The Journal of Immunology 170 (1), 341-348, 2003 | 185 | 2003 |
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind … LP McGarvey, SS Birring, AH Morice, PV Dicpinigaitis, ID Pavord, ... The Lancet 399 (10328), 909-923, 2022 | 147 | 2022 |
Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF S Allahverdian, N Harada, GK Singhera, DA Knight, DR Dorscheid American journal of respiratory cell and molecular biology 38 (2), 153-160, 2008 | 131 | 2008 |
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies M Nakayama, N Harada, K Okumura, H Yagita Biochemical and biophysical research communications 306 (4), 819-825, 2003 | 84 | 2003 |
TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells Y Itoigawa, N Harada, S Harada, Y Katsura, F Makino, J Ito, F Nurwidya, ... Respiratory research 16, 1-15, 2015 | 77 | 2015 |
Mapping the human genetic architecture of COVID-19: an update COVID-19 Host Genetics Initiative, A Ganna MedRxiv, 2021.11. 08.21265944, 2021 | 65 | 2021 |
DOCK2 is involved in the host genetics and biology of severe COVID-19 H Namkoong, R Edahiro, T Takano, H Nishihara, Y Shirai, K Sonehara, ... Nature 609 (7928), 754-760, 2022 | 53 | 2022 |
ICOS promotes group 2 innate lymphoid cell activation in lungs F Kamachi, T Isshiki, N Harada, H Akiba, S Miyake Biochemical and biophysical research communications 463 (4), 739-745, 2015 | 47 | 2015 |
Cupressaceae pollen grains modulate dendritic cell response and exhibit IgE-inducing adjuvant activity in vivo S Kamijo, T Takai, T Kuhara, T Tokura, H Ushio, M Ota, N Harada, ... The Journal of Immunology 183 (10), 6087-6094, 2009 | 45 | 2009 |
B7-H3 contributes to the development of pathogenic Th2 cells in a murine model of asthma O Nagashima, N Harada, Y Usui, T Yamazaki, H Yagita, K Okumura, ... The Journal of Immunology 181 (6), 4062-4071, 2008 | 45 | 2008 |
Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation T Tsutsumi, T Nagaoka, T Yoshida, L Wang, S Kuriyama, Y Suzuki, ... PLoS One 14 (7), e0214697, 2019 | 42 | 2019 |
TIM-1 signaling in B cells regulates antibody production J Ma, Y Usui, K Takeda, N Harada, H Yagita, K Okumura, H Akiba Biochemical and biophysical research communications 406 (2), 223-228, 2011 | 36 | 2011 |
Wound-induced TGF-β1 and TGF-β2 enhance airway epithelial repair via HB-EGF and TGF-α J Ito, N Harada, O Nagashima, F Makino, Y Usui, H Yagita, K Okumura, ... Biochemical and biophysical research communications 412 (1), 109-114, 2011 | 32 | 2011 |
Circulating activated innate lymphoid cells and mucosal-associated invariant T cells are associated with airflow limitation in patients with asthma A Ishimori, N Harada, A Chiba, S Harada, K Matsuno, F Makino, J Ito, ... Allergology International 66 (2), 302-309, 2017 | 31 | 2017 |
Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis K Wang, JY Verbakel, J Oke, A Fleming-Nouri, J Brewin, N Roberts, ... European Respiratory Journal 55 (5), 2020 | 30 | 2020 |
Cutting edge: anti–TIM-3 treatment exacerbates pulmonary inflammation and fibrosis in mice T Isshiki, H Akiba, M Nakayama, N Harada, K Okumura, S Homma, ... The Journal of Immunology 199 (11), 3733-3737, 2017 | 30 | 2017 |
Clinical characteristics of patients with coronavirus disease (COVID-19): preliminary baseline report of Japan COVID-19 task force, a nationwide consortium to investigate host … H Tanaka, H Lee, A Morita, H Namkoong, S Chubachi, H Kabata, ... International Journal of Infectious Diseases 113, 74-81, 2021 | 29 | 2021 |